- Formulation rooted in traditional Indian knowledge shown to strengthen immunity and ease treatment side effects of cancer
JAIPUR | 28th SEPTEMBER 2025: Cancer continues to be one of the most daunting health challenges globally, yet innovative approaches are offering new rays of hope. Among these, Carctol a formulation developed through India’s healing traditions has shown promising results as a supportive therapy for cancer patients. For decades, it has helped improve resilience, reduce treatment-related discomfort, and enhance the overall quality of life for hundreds of patients in India and abroad.
Independent studies and clinical evaluations have indicated its effectiveness across a wide range of cancers, including those affecting the uterus, breast, liver, lungs, bones, prostate, and blood. Significantly, the Central Council for Research in Ayurvedic Sciences (CCRAS), Government of India, has validated its safety through toxicity testing, confirming it to be free of any side effects.
Reflecting on this journey, Dr. Vipin Tiwari explained: “Nearly 45 years ago, my grandfather, Vaidya Nandlal Tiwari created this unique formulation by combining eight medicinal plants after years of research and practice. Since then, countless patients across the world have experienced its benefits. My mission is simply to make sure more people can access Carctol and find strength in their fight against cancer.”
As a bridge between India’s heritage of healing and modern scientific treatment, Carctol continues to gain recognition as an important complementary approach in cancer management. With ongoing studies and growing patient experiences, it holds the potential to improve countless lives in the years to come.
